These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 23047023

  • 1. Effect of cholinesterase inhibitors on attention.
    Pepeu G, Giovannini MG, Bracco L.
    Chem Biol Interact; 2013 Mar 25; 203(1):361-4. PubMed ID: 23047023
    [Abstract] [Full Text] [Related]

  • 2. Cholinesterase inhibitors and memory.
    Pepeu G, Giovannini MG.
    Chem Biol Interact; 2010 Sep 06; 187(1-3):403-8. PubMed ID: 19941841
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Tacrine].
    Dávila C, Viteri C, de Castro P.
    Rev Med Univ Navarra; 1997 Sep 06; 41(1):58-64. PubMed ID: 9527715
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Have cholinergic therapies reached their clinical boundary in Alzheimer's disease?
    Jones RW.
    Int J Geriatr Psychiatry; 2003 Sep 06; 18(Suppl 1):S7-S13. PubMed ID: 12973745
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alzheimer disease, attention, and the cholinergic system.
    Lawrence AD, Sahakian BJ.
    Alzheimer Dis Assoc Disord; 1995 Sep 06; 9 Suppl 2():43-9. PubMed ID: 8534423
    [Abstract] [Full Text] [Related]

  • 10. Sex influences on cholinesterase inhibitor treatment in elderly individuals with Alzheimer's disease.
    Haywood WM, Mukaetova-Ladinska EB.
    Am J Geriatr Pharmacother; 2006 Sep 06; 4(3):273-86. PubMed ID: 17062329
    [Abstract] [Full Text] [Related]

  • 11. Cholinergic therapies for Alzheimer's disease. Palliative or disease altering?
    Davis RE, Doyle PD, Carroll RT, Emmerling MR, Jaen J.
    Arzneimittelforschung; 1995 Mar 06; 45(3A):425-31. PubMed ID: 7763338
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a "real world" study.
    Mossello E, Tonon E, Caleri V, Tilli S, Cantini C, Cavallini MC, Bencini F, Mecacci R, Marini M, Bardelli F, Sarcone E, Razzi E, Biagini CA, Masotti G.
    Arch Gerontol Geriatr Suppl; 2004 Mar 06; (9):297-307. PubMed ID: 15207427
    [Abstract] [Full Text] [Related]

  • 13. Detecting effects of donepezil on visual selective attention using signal detection parameters in Alzheimer's disease.
    Foldi NS, White RE, Schaefer LA.
    Int J Geriatr Psychiatry; 2005 May 06; 20(5):485-8. PubMed ID: 15852461
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients.
    Almkvist O, Jelic V, Amberla K, Hellström-Lindahl E, Meurling L, Nordberg A.
    Dement Geriatr Cogn Disord; 2001 May 06; 12(1):22-32. PubMed ID: 11125238
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease.
    Vellas B, Cunha L, Gertz HJ, De Deyn PP, Wesnes K, Hammond G, Schwalen S, GAL-INT-28 Study Group.
    Curr Med Res Opin; 2005 Sep 06; 21(9):1423-9. PubMed ID: 16197661
    [Abstract] [Full Text] [Related]

  • 20. [Alzheimer drugs for mild cognitive impairment].
    Fellgiebel A.
    Neuropsychiatr; 2007 Sep 06; 21(3):230-3. PubMed ID: 17915184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.